摘要
背景:尽管情绪和睡眠障碍在阿尔茨海默病(AD)患者中几乎是普遍存在的,但参与非认知加工的脑结构仍然缺乏特征。AD病理学术语。 目的:评价APPswe/PS1dE9家族性AD小鼠脑干AD病理特征。 方法:采用6E10免疫组织化学方法,对6只转基因B6C3小鼠和6只B6C3小鼠新鲜冷冻切片进行淀粉样蛋白负荷和神经原纤维改变的检测。Mistry和Gallyas的银染色,分别。[3H]DASB放射自显影法测定背侧和中缝5-羟色胺转运体(SERT)密度。检测SERT mRNA的表达用RT-PCR和原位杂交观察红色。用免疫组织化学方法检测小胶质细胞和星形胶质细胞的表达,并检测促炎基因的mRNA水平。细胞因子TNF-α、IL-1β和IL-6。 结果:12月龄APPswe/PS1dE9小鼠中脑中缝未见淀粉样蛋白和τ相关病变。与年龄匹配的c基因相比,转基因动物中的塞特结合水平降低。与对照组相比,SERTmRNA水平至少降低了50%。APPswe/PS1dE9与野生型小鼠相比,小胶质细胞强而无星形胶质细胞免疫反应。TN水平F-αmRNA表达水平与转基因动物的SERT mRNA表达水平呈正相关。 结论:12月龄APPswe/PS1dE9小鼠中脑中缝未见淀粉样变及τ相关病理改变。然而,有局部神经炎症反应,失去了5-羟色胺能标记物,可部分解释AD的一些行为症状。
关键词: 阿尔茨海默病,脑干,中缝背,中缝,SERT,神经炎症,APPswe/PS1dE9。
Current Alzheimer Research
Title:Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice
Volume: 15 Issue: 5
关键词: 阿尔茨海默病,脑干,中缝背,中缝,SERT,神经炎症,APPswe/PS1dE9。
摘要: Background: Although mood and sleep disturbances are nearly universal among patients with Alzheimer's disease (AD), brain structures involved in non-cognitive processing remain under characterized in terms of AD pathology.
Objectives: This study was designed to evaluate hallmarks of AD pathology in the brainstem of the APPswe/PS1dE9 mouse model of familial AD.
Methods: Fresh-frozen sections from female, 12 month old, transgenic and control B6C3 mice (n=6/genotype) were examined for amyloid burden and neurofibrillary alterations, by using 6E10 immunohistochemistry and the Gallyas silver stain, respectively. Serotonin transporter (SERT) densities in the dorsal and the median raphe were quantified by [3H]DASB autoradiography. SERT mRNA expression was measured by RT-PCR and visualized by in situ hybridization. Neuroinflammation was evaluated by immunohistochemical staining for microglia and astrocytes, and by measuring mRNA levels of the proinflammatory cytokines TNF-α, IL-1β and IL-6.
Results: No amyloid- and tau-associated lesions were observed in the midbrain raphe of 12 month old APPswe/PS1dE9 mice. SERT binding levels were reduced in transgenic animals compared to age-matched controls, and SERT mRNA levels were decreased by at least 50% from control values. Intense microglial, but not astrocytic immunoreactivity was observed in APPswe/PS1dE9 vs. wild-type mice. Levels of TNF-α mRNA were two-fold higher than control and correlated positively with SERT mRNA expression levels in transgenic animals.
Conclusions: There was no amyloid accumulation and tau-associated pathology in the midbrain raphe of 12 month old APPswe/PS1dE9 mice. However, there was a local neuroinflammatory response with loss of serotonergic markers, which may partially account for some of the behavioral symptoms of AD.
Export Options
About this article
Cite this article as:
Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice, Current Alzheimer Research 2018; 15 (5) . https://dx.doi.org/10.2174/1567205014666171004113537
DOI https://dx.doi.org/10.2174/1567205014666171004113537 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biocompatible Targeting Hydrogels for Breast Cancer Treatment
Mini-Reviews in Medicinal Chemistry Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Interpreting the Mechanisms by which Integrins Promote the Differentiation of Mesenchymal Stem Cells and Integrin Application Prospects
Current Stem Cell Research & Therapy Clinical Experience with Therapeutic Vaccines Designed for Patients with Hepatitis
Current Pharmaceutical Design Improvement of Tumor Localization of Photosensitizers for Photodynamic Therapy and Its Application for Tumor Diagnosis
Current Topics in Medicinal Chemistry Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel
Current Topics in Medicinal Chemistry Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions
Current Drug Therapy Drug Delivery Systems for Brain Tumor Therapy
Current Pharmaceutical Design Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?
Current Medicinal Chemistry Ketogenic Diet Acts on Body Remodeling and MicroRNAs Expression Profile
MicroRNA Anti-Angiogenic Approaches to Malignant Gliomas
Current Cancer Drug Targets The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Current Molecular Medicine Nanoprobes for Medical Diagnosis: Current Status of Nanotechnology in Molecular Imaging
Current Nanoscience Perspectives/Opinion: ADVANCED MEDICAL IMAGING IN THE ERA OF PERSONALIZED OR PRECISION MEDICINE
Current Medical Imaging Recent Patents, Regulatory Issues, and Toxicity of Nanoparticles in Neuronal Disorders
Current Drug Metabolism Medicinal Chemistry of Indolylglyoxylamide TSPO High Affinity Ligands with Anxiolytic-Like Effects
Current Topics in Medicinal Chemistry The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Preparation, Pharmacokinetic and Application of Gold Nanoclusters (AuNCs) in Tumor Treatment
Current Medicinal Chemistry Subject Index To Volume 7
Current Drug Targets